Senior Connect Acquisition I said it has entered into a non-binding letter of intent for a business combination with Avellino Lab USA.
Avellino is engaged in precision genetics medicine, bringing diagnostics, therapies, and AI-driven data processing to patient care.
The SPAC expects to announce additional details regarding the proposed business combination when a definitive agreement is executed, which is expected early in the first quarter of 2023.
Senior Connect I raised $414 million in a December 2020 IPO. Read more.
